Please select your view
The Osteoporosis Risk Assessment (NTx) measures the risk of osteoporosis by detecting the rate of bone resorption (breakdown) well before significant changes become obvious on bone mineral density scans. This test can also be used to assess the efficacy of anti-resorptive therapies such as hormone replacement therapy (HRT) and/or Calcium supplementation in postmenopausal women, patients with osteoporosis and patient with Paget’s disease.
This testing requires two urine samples taken from the first morning void (the first urination after waking in the morning).
Plastic sample bag
2 x 15ml plastic urine tube
5ml plastic eye dropper
Padded postage satchel
- It is recommended that you do not engage in excessive exercise the day before the test
- Follow your normal diet the day before the test
- Urine collection should be from the second morning void (i.e. the second time you urinate after waking for the day)
- It is not necessary to stop taking supplements to complete this test